Why the study?
Does percutaneous edge-to-edge MitraClip therapy improve outcomes in patients with mitral regurgitation compared to surgical repair or historical controls?
Population
Patients with mitral regurgitation, particularly those at high surgical risk
Comparison
Percutaneous edge-to-edge MitraClip therapy vs Surgical mitral valve repair or historical…
Design
Review
Authors
Loading...
Supports MitraClip consideration in high-surgical-risk patients; leaves open long-term efficacy and durability.
Does percutaneous edge-to-edge MitraClip therapy improve outcomes in patients with mitral regurgitation compared to surgical repair or historical controls?
MitraClip therapy offers a safe, percutaneous alternative for managing mitral regurgitation, particularly in high-surgical-risk patients, though long-term durability remains under investigation.
Rogers et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: